div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=documentpdf-intravenz-ld50-deerleri-slraswla-77-ve-83-mgkg-dlr-5-farmakolojikhtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: pdfilacprospektusucom · intravenöz LD50 dežerleri slraswla 77 ve 83 mgkg dlr 5 FARMAKOLOJiK ÖZELLiKLER 51 Farmakodinamik özellikler Farmakoterapötik grup: H2-Reseptör loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader036fdocumentscoreader036viewer20220814096079071e6ad1173ec56c2ff2html5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=documentpdf-intravenz-ld50-deerleri-slraswla-77-ve-83-mgkg-dlr-5-farmakolojikhtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: pdfilacprospektusucom · intravenöz LD50 dežerleri slraswla 77 ve 83 mgkg dlr 5 FARMAKOLOJiK ÖZELLiKLER 51 Farmakodinamik özellikler Farmakoterapötik grup: H2-Reseptör loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader036fdocumentscoreader036viewer20220814096079071e6ad1173ec56c2ff2html5thumbnails2jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imageimg data-url=documentpdf-intravenz-ld50-deerleri-slraswla-77-ve-83-mgkg-dlr-5-farmakolojikhtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: pdfilacprospektusucom · intravenöz LD50 dežerleri slraswla 77 ve 83 mgkg dlr 5 FARMAKOLOJiK ÖZELLiKLER 51 Farmakodinamik özellikler Farmakoterapötik grup: H2-Reseptör loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader036fdocumentscoreader036viewer20220814096079071e6ad1173ec56c2ff2html5thumbnails3jpg...